After a turbulent nine months, the organisation has appointed a new CEO. There’s also news from Neuren Pharmaceuticals and Cure Cancer.
After a turbulent nine months, the organisation has appointed a new CEO. There’s also news from Neuren Pharmaceuticals and Cure Cancer.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.